Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2634-2643

  Kelley, Mary J ^a   Rose, Anastasia Y ^a   Song, Kaili ^a   Chen, Yanwen ^a   Bradley, John M ^a   Rookhuizen, Derek ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MMP3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME PHOSPHORYLATION; GLAUCOMA; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; MICROARRAY ANALYSIS; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CULTURE TECHNIQUE; DNA MICROARRAY; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; TRABECULAR MESHWORK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347233851     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1445     Document Type: Article

References (32)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
3. Parshley DE, Bradley JMB, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795-804.
4. Parshley DE, Bradley JMB, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vivo laser treatment to the trabecular meshwork. Curr Eye Res. 1995;14:537-544.
5. Bradley JMB, Vranka JA, Colvis CM, et al. Effects of matrix metalloproteinase activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
6. Bradley JMB, Kelley MJ, Zhu XH, Anderssohn AM, Alexander JP, Acott TS. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci. 2001;42:1505-1513.
7. Bradley JMB, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNF-α. Invest Ophthalmol Vis Sci. 2000;41:422-430.
8. Alexander JP, Acott TS. Involvement of Erk-MAP kinase pathway in TNF-α regulation of trabecular metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2003;44:164-169.
9. Alexander JP, Acott TS. Involvement of protein kinase C in TNF-α regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci. 2001;42:2831-2838.
10. Hosseini M, Rose AY, Song K, et al. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork. Invest Ophthalmol Vis Sci. 2006;47:1469-1476.
11. Pang IH, Fleenor DL, Hellberg PE, Stropki K, McCartney MD, Clark AF. Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression. Invest Ophthalmol Vis Sci. 2003;44:3502-3510.
12. Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-3493.
13. Fleenor DL, Pang IH, Clark AF. Involvement of AP-1 in interleukin-1alpha-stimulated MMP-3 expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3494-3501.
14. Witek-Zawada B, Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes. J Physiol Pharmacol. 2003;54:489-496.
15. Stapp JM, Sjoelund V, Lassiter HA, Feldhoff RC, Feldhoff PW. Recombinant rat IL-1β and IL-6 synergistically enhance C3 mRNA levels and complement component C3 secretion by H-35 rat hepatoma cells. Cytokine. 2005;30:78-85.
16. Lin FS, Lin CC, Chien CS, Luo SF, Yang CM. Involvement of p42/p44 MAPK, JNK, and NFKB in IL-1β-induced ICAM-1 expression in human pulmonary epithelial cells. J Cell Physiol. 2005;202:464-473.
17. Koshy PJ, Henderson N, Logan C, Life PF, Cawston TE, Rowan AD. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis. 2002;61:704-713.
18. Ragab AA, Nalepka JL, Bi Y, Greenfield EM. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol. 2002;283:C679-C687.
19. Cutolo M. IL-1Ra: its role in rheumatoid arthritis. Reumatismo. 2004;56:41-45.
20. Yao S, Wise GE. Regulation of gene expression of tumour necrosis factor-alpha by protein kinase C in the rat dental follicle. Arch Oral Biol. 2003;48:643-648.
21. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med. 2001;7:304-309.
22. Alvarado JA, Alvarado RG, Yeh RF, Franse-Carman L, Marcellino GR, Brownstein MJ. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells. Br J Ophthalmol. 2005;89:1500-1505.
23. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
24. Polansky JR, Weinreb R, Alvarado JA. Studies on human trabecular cells propagated in vitro. Vision Res. 1981;21:155-160.
25. Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells, I: establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049.
26. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
28. Vittal V, Rose A, Gregory KE, Kelley MJ, Acott TS. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2005;46:2857-2868.
29. Kelley MJ, Rose A, Song K, Lystrup B, Samples JW, Acott TS. p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells. Invest Ophthalmol Vis Sci. In press.
30. LeGrand A, Fermor B, Fink C, et al. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in expiants of human osteoarthritic knee menisci. Arthritis Rheum. 2001;44:2078-2083.
31. Demircan N, Safran BG, Soylu M, Ozean AA, Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF-) levels in proliferative diabetic retinopathy. Eye. 2006;20:1366-1369.
32. Raitano AB, Korc M. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors. Cancer Res. 1993;53:636-640.